FDA approval of lymphoma medicine Ukoniq (umbralisib) is withdrawn due to safety concerns
en Español Drug Safety Conversation (PDF – 197 KB) 6-1-2022 Food and drug administration Drug…
en Español Drug Safety Conversation (PDF – 197 KB) 6-1-2022 Food and drug administration Drug…
Linda Rider